The global humanitarian leader in the fight against hip dysplasia

October 17, 2018
00:0000:00

 

CharlesPrice_Oct18_350.jpg

 

Dr. Charles T. Price, Medical Director of the International Hip Dysplasia Institute (IHDI), a global consortium of physicians who come together to share their expertise in a coordinated effort to promote best practices for the prevention, diagnosis and treatment of hip dysplasia joins eHealth Radio and the Health News Channel.

 

Listen to interview with host Eric Michaels and guest Dr. Charles T. Price discuss the following:

  1. What is hip dysplasia?
  2. How common is hip dysplasia and what are the risk factors?
  3. What are the symptoms and how is it diagnosed?
  4. Can hip dysplasia be prevented?
  5. Who is the International Hip Dysplasia Institute (IHDI) and what do they do?
  6. As a new parent, what can we do to protect our newborns?

 

Dr. Charles Price is a pediatric orthopaedic surgeon at the Arnold Palmer Hospital for Children in Orlando, Florida and director of the International Hip Dysplasia Institute which he established with the help of comedian Larry the Cable Guy in 2009.

A past president of the Pediatric Orthopaedic Society of North America (POSNA) and the Limb Lengthening and Reconstruction Society of North (ASAMI), Dr. Price was chairman for 10 years of the International Pediatric Orthopaedic Symposium which he formed in 1998.  He was instrumental in developing the muscularskeletal module for the University of Central Florida College of Medicine.

Dr. Price has contributed to the advancement of pediatric orthopaedics in the areas of limb lengthening, limb deformity correction, non-operative and operative management of scoliosis, and hip disorders in children.  He is internationally known for his clinical and academic achievements including numerous scientific publications and book chapters on a variety of subjects.

His wide range of knowledge brings a perspective of experience that is extremely valuable to the group.

 

IHDIlongc_600.jpg

 

Website: hipdysplasia.org

Email: info@hipdysplasia.org

Dr. Charles Brenner on the Surprising Science of Aging

October 11, 2018
00:0000:00

 

CharlesBrennerPHD_350.jpg

 

Dr. Charles Brenner, the Roy J. Carver Chair of Biochemistry at the University of Iowa and Chief Scientific Advisor at ChromaDex, the makers of TRU NIAGEN joins eHealth Radio & the Health News Channel to discuss surprising science behind aging.

 

Listen to interview with host Eric Michaels and guest Dr. Charles Brenner discuss the following:

  1. What is NAD? What has your research revealed about it?
  2. What is the relationship between NAD and aging?
  3. What is NIAGEN, and how is it related to NAD?
  4. Does increasing NAD levels have any other benefits, besides anti-aging? Are these potential benefits being studied in clinical studies?  

 

Dr. Charles Brenner Dr. Charles Brenner is the Roy J. Carver Chair and Head of Biochemistry at the University of Iowa, as well as a founding co-director of the University of Iowa Obesity Initiative. In 2004, Brenner, then a faculty member at Dartmouth College, discovered nicotinamide riboside (NR) to be a vital precursor of nicotinamide adenine dinucleotide (NAD+), which is made available by nicotinamide riboside kinases (Nrks) that are conserved between yeast and humans. In 2007, Dr. Brenner's lab discovered a second pathway by which NR is converted to NAD+ and showed that NR can extend the lifespan of yeast cells by virtue of elevating NAD+ levels and increasing the activity of the NAD+ dependent Sir2 enzyme.

In the past decade, Dr. Brenner has made multiple seminal contributions to NAD+ metabolism, which include engineering a yeast strain to convert inexpensive NAD+ precursor vitamins into NR, solving the crystal structure of human Nrk1, developing the methods for quantitative NAD+ metabolomics, and demonstrating the activity of oral NR in animal models of fatty liver disease, obesity, type 2 diabetes, diabetic and chemotherapeutic neuropathy, heart failure, and central brain injury. Dr. Brenner also led the first clinical trial of NR, which established safe oral availability in humans. He is currently focusing on the maternal and neonatal effects of oral NR and translating animal discoveries into evidence-based safe, human clinical practice for human conditions of metabolic stress.

 

Tru_Niagen_logo.jpg

 

Website: www.truniagen.com | www.aboutNAD.com

Social Media Links:
Facebook: https://www.facebook.com/TruNiagen
Twitter: https://twitter.com/truniagen

Medical device company focused on developing restoration treatments for patients with spinal cord-injuries

October 5, 2018
00:0000:00

 

1513661252_Richard_Toselli_1_.jpg

 

Dr. Richard Toselli, CEO of the InVivo Therapeutics Corporation a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries joins eHealth Radio and the Health News & Spinal Health Channels.

 

Listen to interview with host Eric Michaels and guest Dr. Richard Toselli discuss the following:

  1. Can you tell our audience about InVivo Therapeutics and what your company does?
  2. You have an interesting background for a CEO, not a typical one. You’re a former neuro surgeon. Can you tell our audience which has an interest in healthcare and business a bit about your background and how it translates to your current role as CEO of InVivo Therapeutics?
  3. What’s more difficult and challenging being a neuro-surgeon or the ceo of a publicly traded company haha?
  4. You became CEO earlier this year, and reading some news on you and the company it was reported that you have made some major changes with the company under your leadership such as decreasing the cash burn rate, launching a second spinal trial. Can you discuss that and also discuss the second trial as well.
  5. Can you talk a bit about product development with your company and how the process works so our listeners can understand.
  6. The spinal chord industry is constantly evolving and changing. Can you chat a bit about the industry and where it’s going and where your company fits within this industry.
  7. We know wall street is not always patient. How do companies like yours juggle the interests of investors with what you do with research and development and clinical trials etc.
  8. Where do you see this company going in the next 3 to 5 years, what do you hope to accomplish.

 

Prior to joining InVivo, Dr. Toselli served as Chief Medical Officer for Cochlear Limited. In that role, he was responsible for global clinical, regulatory, and medical affairs teams reporting to the CEO. Prior to that, Dr. Toselli served five years at Sanofi in various levels of increasing responsibility, including Vice President of Global Medical Affairs – Immunology and Inflammation, Biologics Division; Vice President of Global Medical Affairs and Head of the Biosurgery Discovery Performance Unit; and Vice President of Global Medical Affairs, Biosurgery.

Before his time at Sanofi, he served as Chief Medical/Technology Officer for Covidien Surgical, and earlier held various roles at DePuy Spine including Director of Medical Affairs, Worldwide Vice President of Research and Development, and Worldwide Vice President of Clinical Evidence and External Relations. He subsequently held the position of Vice President of Evidence-Based Medicine at Johnson & Johnson for the device sector.

Dr. Toselli’s previous academic positions include Assistant Professor at Brown University, Associate Professor, Director of Spine Center, and Associate Chief of Staff at the University of North Carolina (UNC), and Associate Professor at the University of Vermont. He holds a bachelor of arts from Providence College, his medical degree from Brown University, and a masters of business administration from the UNC’s Kenan-Flagler Business School. Dr. Toselli is a board-certified neurological surgeon.

InVivo Therapeutics Holdings Corporation is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. In January 2018, the company announced updated clinical evidence, including improvements in patients with acute spinal cord injury (SCI), from its INSPIRE study of the Neuro-Spinal Scaffold™. The publicly traded company is headquartered in Cambridge, MA.

 

INVIVO_LOGO.jpg

 

Website: www.invivotherapeutics.com

#Trichotillomania: What it is & how you can take control with HabitAware CoFounder, Aneela Idnani

October 4, 2018
00:0000:00

 

Aneela_350.jpg

 

Aneela Idnani, Co-Founder & "Chief Trichster" at HabitAware joins eHealth Radio and the Health News & Technology Channels. She is the inspiration for HabitAware's Keen smart bracelet to help people overcome unwanted behaviors like compulsive hair pulling, skin picking and nail biting.

 

Listen to interview with host Eric Michaels and guest Aneela Idnani discuss the following:

  1. Tell us a little bit about your experience with compulsive hair pulling disorder, also known as trichotillomania?
  2. How did you come up with the idea to use technology to help you & how does the Keen bracelet work?
  3. What resources are out there for someone who may just be realizing they have Body Focused Repetitive Behaviors?
  4. What does recovery mean to you personally?
  5. Can you please share one thing someone can do today to get started on their journey to BFRB awareness and recovery?

 

HabitAware-products.jpg

 

Aneela Idnani is Cofounder & President/CMO of HabitAware. HabitAware uses patented wearable technology to help people “Retrain The Brain” from detrimental behaviors to positive ones and on becoming the standard of care for debilitating mental health conditions.

Aneela is also an outspoken mental health advocate, having grown up with a common, yet relatively unknown condition called #trichotillomania (compulsive hair pulling). Aneela is a HAX hardware accelerator alumnus and her company recently received a research grant from the NIH to improve their device and validate Keen as a treatment for trichotillomania and sister disorders. Her life’s work (HabitAware) has been featured on TechCrunch, The Washington Post, Prevention Magazine and more.

 

KeenLogo_FULL.jpg

 

Website: www.habitaware.com

Social Media Links:
Facebook: www.facebook.com/habitaware
Twitter: www.twitter.com/habitaware
Instagram: www.instagram.com/habitaware

Movement and Your Musculoskeletal Health

October 3, 2018
00:0000:00

 

Hayden_Robert_350_Oct18.jpg

 

Dr. Robert Hayden, DC, PhD, a Chiropractor from Griffin, Georgia, who is also a delegate of the American Chiropractic Association joins eHealth Radio and the Chiropractic & Health News Channels. ACA represents members of the chiropractic profession nationwide and advocates for issues that are important to chiropractors and their patients.

 

Listen to interview with host Eric Michaels and guest Dr. Robert Hayden discuss the following:

  1. We hear a lot about how physical activity can benefit our cardiovascular system, help us lose weight and get fit. But how does movement help our bones, muscles and joints—also known as the musculoskeletal system?
  2. Why does moving get harder as we age? Can we prevent or slow down the aging process on our bones, muscles and joints?
  3. In your experience, what are the top reasons why people aren’t moving more?
  4. For years we were told to restrict physical activity when we had back pain. Why was that bad advice? How does movement help people heal?
  5. How can people get moving? What are some of the best activities for those who may be largely inactive right now?

 

Dr. Robert Hayden maintains a private practice in Griffin, Georgia, just south of Atlanta. Dr. Hayden is a past president of the Georgia Chiropractic Association and was named the organization’s "Chiropractor of the Year" in 2006.

Prior to receiving his doctor of chiropractic degree, Dr. Hayden was a cardiovascular clinical nurse specialist. He devoted 18 years to the nursing profession, serving as executive director of the Mississippi Nurses’ Association, and as a registered lobbyist and continuing education consultant.

Dr. Hayden holds bachelor’s degrees in chemistry and nursing, and received his master’s degree in nursing from the University of Alabama. He also holds a PhD from the University of Mississippi and in 1995 received his doctor of chiropractic degree from Life University.

 

ACAlogo_NEW_350_Oct18.jpg

 

Website: www.acatoday.org

Social Media Links:
Facebook: www.facebook.com/acatoday.org
Twitter: www.twitter.com/acatodaday

Brain U Online, the first scientifically-supported cognitive training program

September 27, 2018
00:0000:00

 

DrJohnDenBoer.jpg

 

Dr. John DenBoer of Smart Brain Aging, a company that has developed Brain U Online - one of the few "digital prescriptions" reimbursable to Medicare and shown to have a very positive effect on the quality of people's lives joins eHealth Radio and the Health News and Mental Health Channels.

 

Listen to interview with host Eric Michaels and guest Dr. John DenBoer discuss the following:

  1. How did you start your interest in studying Dementia?
  2. Can you explain please how Brain U Online works?
  3. What has been the benefits to Brain U Online in addition to it preventing memory loss and mitigate decline?
  4. Why has Brain U Online become one of the first "Digital Prescriptions" to be covered by Medicare?
  5. What do you see for the future of Brain U Online?

 

Dr. John DenBoer is a Clinical Neuropsychologist specializing in the assessment and detection of early-stage dementia. He received his internship training at VA Boston Healthcare System (Boston University School of Medicine/Harvard University) and received his postdoctoral training at Barrow Neurological Institute. He has published extensively in the area of Clinical Neuropsychology and has been an expert speaker at many local, national, and international conferences. He is the Founder, CEO, and Chief Medical Officer of SMART Brain Aging, Inc., a company designed to help prevent and intervene in mild cognitive impairment and early-stage dementia.

In the last 3 years he has become a world-renown speaker in the area of early-stage dementia detection and treatment. This has culminated in a Netflix documentary and corresponding book, entitled “This is Dementia?!“.

 

BrainUOnline_LOGO.jpg

 

Websites: www.brainuonline.com | www.smartbrainaging.com

Social Media Links:
Facebook: facebook.com/smartbrainaging
Twitter: twitter.com/smartbrainaging

Dr. Kavita Mariwalla on the Impact of Seborrheic Keratoses and New Treatment for Patients

September 19, 2018
00:0000:00

 

KavitaMariwalla_350.jpg

 

Dr. Kavita Mariwalla, a Board Certified Dermatologist and a paid spokesperson for Aclaris Therapeutics & ESKATA joins eHealth Radio and the Dermatology and Health News Channels to talk about the impact of seborrheic keratoses and a new treatment for patients.

 

Listen to interview with host Eric Michaels and guest Dr. Kavita Mariwalla discuss the following:

  1. What are seborrheic keratoses (SKs) and how do people get them?
  2. What is ESKATA® 40 % hydrogen peroxide topical solution, and how is it used?
  3. What other treatments are available to address SKs?
  4. What did the clinical studies of ESKATA® 40 % hydrogen peroxide topical solution show? What are the benefits and potential side effects?
  5. Why is this new treatment important for your patients?

 

Dr. Kavita Mariwalla is a nationally recognized leader in dermatology and dermatologic surgery, whose expertise is in the areas of anti-aging procedures and skin cancer treatment.

Prior to starting her own private practice, Dr. Mariwalla was the Director of Cutaneous Oncology at St. Luke’s – Roosevelt and Beth Israel Medical Centers in New York. Dr. Mariwalla has been recognized for extensive work in the area of dermatologic education and is considered an expert injector of fillers and neuromodulators. She has written two editions of the widely used book, “Primer in Dermatologic Surgery,” which is highly regarded by residents and seasoned dermatologic surgeons and is author of the “Cosmeceutical Compendium.” Dr. Mariwalla is editor of “Surgical Pearls” for the Journal of the American Academy of Dermatology and sits on the Board of Directors of the Women’s Dermatologic Society and American Society for Dermatologic Surgery.

In addition, Dr. Mariwalla is noted for sharing her injection techniques during live demonstrations at the American Academy of Dermatology annual meetings. Her private practice has been nominated for the “Best of Long Island,” since its inception in 2012.

Dr. Mariwalla earned her degree in medicine at the Yale School of Medicine where she also completed her dermatology residency and fellowship training.

 

ESKATA_R_logo_RGB.jpg

 

Websites: www.eskata.com | www.mariwalladermatology.com

Curable, The Chronic Pain Self-Help App

September 15, 2018
00:0000:00

 

JohnGribbin.jpg

 

John Gribbin, CEO and Co-Founder of Curable the healthcare technology company to help manage chronic pain joins eHealth Radio and the Pain Management and Technology Channels.

 

Listen to interview with host Eric Michaels and guest John Gribbin discuss the following:

  1. What is Curable?
  2. Why did you decide to start Curable?
  3. What is a biopsychosocial approach and how does it help with pain relief on the app?
  4. What has been the response from the medical community and the users?
  5. Where do you see Curable headed in the future as a company and as a solution to chronic pain?

 

John Gribbin is the CEO and a co-founder of Curable. John is an experienced entrepreneur across multiple industries. He is also a former 15-year sufferer of chronic low back pain. Through the treatment method Curable delivers, he was able to completely resolve his pain symptoms and limitations.

 

Curable_Logo.jpg

 

Website: www.curablehealth.com 

Facebook: www.facebook.com/curablehealth

What to Expect with Psychotherapy

September 12, 2018
00:0000:00

 

DavidCollins.jpg

 

David Collins, from the Toronto-based, Psychotherapy Referral Service that helps over 200 people every year connect with individuals as well as family and couple therapists to help them deal with their emotional and mental health issues joins eHealth Radio and the Health News and Mental Health Channels.

 

Listen to interview with host Eric Michaels and guest David Collins discuss the following:

  1. There are people out there who may not believe that “talking about your problems to a therapist” will help them in any way. What would you say are the key benefits of therapy?
  2. For people who maybe have never experienced therapy, can you explain basically how psychotherapy works?
  3. What is PRS?
  4. How is professional therapy different from merely talking to friends and family about things that bother you?
  5. What are the indicators that a person should seek therapy?

 

David Collins is a Registered Psychotherapist that specializes in Emotional Disturbance, Childhood Abuse, Self-Harm, and Gender Issues. He strives to establish a strong rapport so that there hopefully will be nothing too shameful, sorrowful or unnatural, that it cannot be discussed. David believes that unlike our everyday lives, the therapeutic relationship is a unique bubble where we hopefully can feel free of the impingements of society for an hour every week to feel, consider and discuss whatever is our inner truth at the time. If in here we can get beyond the everyday self-censoring, we can engage in a real discussion of issues that may be controlling our lives, but from the shadows beyond our conscious attention.

 

PRSLogo.jpg

Website: www.prstoronto.com

Losing hair? We have a safe solution for you, the Theradome

September 11, 2018
00:0000:00

 

TamimHamid_500.jpg

 

Tamim Hamid, the Inventor of Theradome, the world's most advanced laser hair growth treatment for at home use to stop hair loss and regrow hair joins eHealth Radio and the Hair Health and Health News Channels.

 

Listen to interview with host Eric Michaels and guest Tamim Hamid discuss the following:

  1. From what I have heard August is Hair Loss Awareness Month... can you tell us a little about this?  
  2. Where did the idea to invent Theradome come from?
  3. What is Theradome and why use it?
  4. How does Theradome work?  
  5. Besides utilizing Theradome, are there any other strategies or practices you recommend people use to assist with hair loss?

 

Theradome was founded by a former NASA scientist, Tamim Hamid. Hamid’s educational background consists of a Bachelor of Science in Electrical Engineering, Master of Science in Computer Engineering and a PhD in Biomedical Engineering. Utilizing his edification and his experience, Hamid invented the Theradome laser hair restoration helmet.

The Theradome is a trusted name in clinical-strength hair restoration therapies and is dedicated to developing the world’s most technologically advanced, science-based laser phototherapy hair-growth solutions. To date Theradome’s professional laser phototherapy devices have delivered more than 4,000,000 treatments across 5 continents and are distributed by thousands of hair restoration professionals worldwide. Theradome is a breakthrough technology and we want to make it available and affordable for everyone to use in the comfort and privacy of their home.

 

THERADOME_LOGO_R_SRGB_760.jpg

 

Website: https://www.theradome.com
Facebook: https://www.facebook.com/Theradome